An evidence-based approach to postpartum use of depot medroxyprogesterone acetate in breastfeeding women

Contraception

Volumn 80, Issue 1, 2009, Pages 4-6

  Rodriguez, Maria Isabel ^a   Kaunitz, Andrew M ^b  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GESTAGEN; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ARTICLE; BREAST FEEDING; CLINICAL TRIAL; CONTRACEPTION; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED PRACTICE; FAMILY PLANNING; HUMAN; LACTATION; MILK PRODUCTION; PUERPERIUM; WORLD HEALTH ORGANIZATION;

EID: 67349262448     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2008.12.014     Document Type: Note

References (27)

1. Glasier A., Brechin S., Raine R., and Penney G. A consensus process to adapt the World Health Organization selected practice recommendations for UK use. Contraception 68 (2003) 327-333
2. World Health Organization. Medical Eligibility Criteria for Contraceptive Use. 3rd ed. (2004), World Health Organization, Geneva
3. Speroff L., and Mishell Jr. D.R. The postpartum visit: it's time for a change in order to optimally initiate contraception. Contraception 78 (2008) 90-98
4. Halderman L.D., and Nelson A.L. Impact of early postpartum administration of progestin-only hormonal contraceptives compared with nonhormonal contraceptives on short-term breast-feeding patterns. Am J Obstet Gynecol 186 (2002) 1250-1256
5. Darney P., and Speroff L. A clinical guide for contraception. 4th ed. (2005), Lippincott Williams & Wilkins, Philadelphia (PA)
6. Tankeyoon M., Dusitsin N., Chalapati S., et al. Effects of hormonal contraceptives on milk volume and infant growth: WHO Special Programme of Research and Development and Research Training in Human Reproduction. Contraception 30 (1984) 505-522
7. World Health Organization, Task Force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development, and and Research Training in Human Reproduction. Progestogen-only contraceptives during lactation: II. Infant development. World Contraception 50 (1994) 55-68
8. World Health Organization, Task Force for Epidemiological Research on Reproductive Health; Special Programme of Research, and Development and Research Training in Human Reproduction. Progestogen-only contraceptives during lactation: I. Infant growth. Contraception 50 (1994) 35-53
9. Jimenez J., Ochoa M., Soler M.P., and Portales P. Long-term follow-up of children breast-fed by mothers receiving depot-medroxyprogesterone acetate. Contraception 30 (1984) 523-533
10. Kennedy K.I., Short R.V., and Tully M.R. Premature introduction of progestin-only contraceptive methods during lactation. Contraception 55 (1997) 347-350
11. Queenan J.T. Contraception and breastfeeding. Clin Obstet Gynecol 47 (2004) 734-739
12. Koetsawang S. The effects of contraceptive methods on the quality and quantity of breast milk. Int J Gynaecol Obstet 25 Suppl (1987) 115-127
13. Baheiraei A., Ardsetani N., and Ghazizadeh S. Effects of progestogen-only contraceptives on breast-feeding and infant growth. Int J Gynaecol Obstet 74 (2001) 203-205
14. ACOG practice bulletin. No. 73: use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol 107 (2006) 1453-1472
15. Culwell K.R., and Feinglass J. Changes in prescription contraceptive use, 1995-2002: the effect of insurance status. Obstet Gynecol 110 (2007) 1371-1378
16. Kelsey J.J. Hormonal contraception and lactation. J Hum Lact 12 (1996) 315-318
17. Guiloff E., Ibarra-Polo A., Zanartu J., Toscanini C., Mischler T.W., and Gomez-Rogers C. Effect of contraception on lactation. Am J Obstet Gynecol 118 (1974) 42-45
18. Karim M., Ammar R., el-Mahgoub S., el-Ganzoury B., Fikri F., and Abdou I. Injected progestogen and lactation. Br Med J 1 (1971) 200-203
19. Patel S.B., Toddywalla V.S., Betrabet S.S., et al. At what 'infant-age' can levonorgestrel contraceptives be recommended to nursing mothers?. Adv Contracept 10 (1994) 249-255
20. Virutamasen P., Leepipatpaiboon S., Kriengsinyot R., et al. Pharmacodynamic effects of depot-medroxyprogesterone acetate (DMPA) administered to lactating women on their male infants. Contraception 54 (1996) 153-157
21. Sas M., Gellen J.J., Dusitsin N., et al. An investigation on the influence of steroidal contraceptives on milk lipid and fatty acids in Hungary and Thailand. WHO Special Programme of Research, Development and Research Training in Human Reproduction. Task Force on Oral Contraceptives. Contraception 33 (1986) 159-178
22. New IPPF statement on breastfeeding, fertility and post-partum contraception. IPPF Med Bull 24 (1990) 2-4
23. Kaunitz A.M. Injectable long-acting contraceptives. Clin Obstet Gynecol 44 (2001) 73-91
24. Kaunitz A. Depot medroxyprogesterone acetate for contraception-II. In: Rose B.D. (Ed). Uptodate (2008), Uptodate, Wellesley (MA)
25. Xiang A.H., Kawakubo M., Kjos S.L., and Buchanan T.A. Long-acting injectable progestin contraception and risk of type 2 diabetes in Latino women with prior gestational diabetes mellitus. Diabetes Care 29 (2006) 613-617
26. Truitt S.T., Fraser A.B., Grimes D.A., Gallo M.F., and Schulz K.F. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation. Cochrane Database Syst Rev (2003) CD003988
27. Culwell K.R., and Feinglass J. The association of health insurance with use of prescription contraceptives. Perspect Sex Reprod Health 39 (2007) 226-230